Search In this Thesis
   Search In this Thesis  
العنوان
Immunohistochemical Expression of Survivin
and SOX9 in Gastric Carcinoma :
المؤلف
Harras, Heba Fouad Khalifa.
هيئة الاعداد
باحث / هبه فؤاد خليفه هراس
مشرف / وفاء عبد الحليم الطوخى
مشرف / عظيمه جمال نصير
مشرف / حسن تحسين شعير
مشرف / منة عبد الحق عبد العظيم
الموضوع
pathology.
تاريخ النشر
2014.
عدد الصفحات
p 269. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب (متفرقات)
تاريخ الإجازة
24/9/2014
مكان الإجازة
جامعة طنطا - كلية الطب - باثولوجيا
الفهرس
Only 14 pages are availabe for public view

from 317

from 317

Abstract

Worldwide, gastric cancer (GC) is the fourth most commonly diagnosed cancer and the second cause of cancer-related deaths, representing
2.2% of total cancer mortality (Xiao et al., 2012). The Egyptian National Cancer Institute (ENCI) reported that the mean incidence of GC represents
1.8% of cancer cases in both sexes in a period from 2002 to 2010 (Alieldin,
2014). Many different systems have been proposed for the histological classification of gastric carcinoma, but the most commonly used are those of
WHO and Lauren. According to Lauren’s classification (Lauren, 1965), gastric carcinoma is classified into; intestinal, diffuse and mixed, while according to WHO classification (Bosman, 2010 ), GC is classified into four major histologic patterns: tubular,papillary, mucinous and poorly cohesive (including signet ring cell carcinoma), plus uncommon histologic variants. GC is classified according to mucin expression (MUC1 and MUC2)
into four mucin phenotypes; Gastric (MUC1+/ MUC2 -), intestinal (MUC1-/ MUC2+), gastrointestinal (MUC1+/ MUC2+) and unclassified (MUC1-/
MUC2-) mucin phenotypes (krstic and Katic, 2008).